The Long-Acting Ca2+-Channel Blocker Azelnidipine Prevents Left Ventricular Remodeling After Myocardial Infarction
Journal of Pharmacological Sciences - Japan
doi 10.1254/jphs.fp0061139
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2007
Authors
Publisher
Japanese Pharmacological Society